The Evolution of the Patient Journey in Pharma (And Why Patients Are More Confused Than Ever)

Описание: How is the patient journey changing in pharma and healthcare?

In this episode of The Patient Experience Podcast, hosts Bob Miglani (former Pfizer executive and CEO of Hoot) and Jason Grossman (biotech and pharma commercial leader) explore how the modern patient journey is evolving and why pharmaceutical companies are facing a growing patient confusion crisis.

Healthcare innovation has dramatically improved treatments, especially in oncology, rare disease, and personalized medicine, but it has also made the patient journey far more complex. Patients today must navigate genetic testing, specialist referrals, insurance approvals, specialty pharmacies, and an overwhelming amount of information from AI tools, social media, and online communities.

Bob and Jason discuss how these changes are reshaping patient services, patient education, and pharma commercial strategy. As doctors have less time to educate patients and therapies become more specialized, patients often leave appointments unsure of what to do next. Many turn to Reddit, ChatGPT, or Google for answers, which can lead to delays in starting therapy or abandoning treatment altogether.

This conversation explores how the shift toward Direct-to-Patient healthcare models, pricing transparency, and digital health platforms is transforming the way pharmaceutical companies engage patients. The episode also examines what pharma leaders, patient services teams, and patient engagement professionals must do to better support patients through education, trust, and physician-guided communication.

If you work in pharma, biotech, patient services, market access, or patient engagement, this episode will help you understand how the patient journey is changing and what it means for the future of patient experience.